A significant advance in cancer study is occurring with the use of VHH fragments to re-engage damaged p53. This vital tumor inhibitor protein is frequently inactivated in various forms of malignancies, leading https://guideyoursocial.com/story7039280/nanobodies-revive-tumor-suppressor-p53-the-new-pathway-for-tumor-therapy